MINIMAL CHANGE DISEASE FOLLOWING THE SECOND DOSE OF PFIZER-BIONTECH (BNT162B1) FOR SARS-COV-2. COINCIDENCE OR CAUSALITY?
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/607cb9e5e2e204c769c87c8b63737409.pdf
Abstract Title
MINIMAL CHANGE DISEASE FOLLOWING THE SECOND DOSE OF PFIZER-BIONTECH (BNT162B1) FOR SARS-COV-2. COINCIDENCE OR CAUSALITY?
First Name *
Juan Carlos
Last Name *
González García
Co-author 1
David Medina Julio dmj25dmj@gmail.com Hospital General Dr. Manuel Gea González Internal Medicine Ciudad de México
Co-author 2
Joana Balderas Juárez jobaju1@hotmail.com Hospital General Dr. Manuel Gea González Nephrology Ciudad de México
Co-author 3
Mauricio Adrián Salinas Ramírez salinasmau89@gmail.com Hospital General Dr. Manuel Gea González Nephrology Ciudad de México
Co-author 4
Erika Karina Tenorio Aguirre karitenorio03@gmail.com Hospital General Dr. Manuel Gea González Internal Medicine Ciudad de México
Co-author 5
María Virgilia Soto Abraham virgiliasoto@gmail.com Hospital de Cardiología Ignacio Chávez Nephropatology Ciudad de México
Co-author 6
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
E-Poster Format Requirements
PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but
must be saved and submitted as PDF file
.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos